BDBM521009 (+)-5-({[6-Bromo-2-(3,3-difluoropiperidin-1-yl)-3-methylquinolin-4-yl]carbonyl}amino)-4-(2-methoxyphenyl)pentanoic acid (Enantiomer 1)::US11149018, Example 289

SMILES COc1ccccc1[C@@H](CCC(O)=O)CNC(=O)c1c(C)c(nc2ccc(Br)cc12)N1CCCC(F)(F)C1

InChI Key InChIKey=ZSWTUFHUSHGSTO-SFHVURJKSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 521009   

TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM521009((+)-5-({[6-Bromo-2-(3,3-difluoropiperidin-1-yl)-3-...)
Affinity DataIC50:  2.40nMAssay Description:For the characterization of test substances in respect of FP antagonism, PGF2α-induced calcium flux in FP-expressing CHEM1 cells (Millipore, HTS...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent